Published in Thromb Res on September 15, 1980
Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet (1978) 3.74
The composition of food consumed by Greenland Eskimos. Acta Med Scand (1976) 2.27
Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr (1975) 2.06
The composition of the Eskimo food in north western Greenland. Am J Clin Nutr (1980) 1.99
Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. Lancet (1971) 1.77
Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation (2001) 1.61
Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet (1979) 1.56
Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. Acta Med Scand (1972) 1.49
Dose-response studies on the effect of n-3 polyunsaturated fatty acids on lipids and haemostasis. Thromb Haemost (1990) 1.47
Abnormal diurnal rhythm of urine output following renal transplantation: the impact of blood pressure and diuretics. Transplant Proc (2010) 1.45
Validity of D-dimer tests in the diagnosis of deep vein thrombosis: a prospective comparative study of three quantitative assays. J Intern Med (2002) 1.42
Plasma 6-keto-PGF1 alpha, thromboxane B2 and PGE2 during diabetic ketoacidosis. Prostaglandins Leukot Essent Fatty Acids (1990) 1.41
The influence of trans fatty acids on health: a report from the Danish Nutrition Council. Clin Sci (Lond) (1995) 1.41
[Hyperlipidemia in children]. Ugeskr Laeger (1993) 1.40
Alpha-linolenic acid and heart rate variability. Nutr Metab Cardiovasc Dis (2000) 1.40
[Homocysteine and cardiovascular disease]. Ugeskr Laeger (2001) 1.39
Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ (1996) 1.22
The effect of N-6 and N-3 polyunsaturated fatty acids on hemostasis, blood lipids and blood pressure. Thromb Haemost (1983) 1.14
Fast food: unfriendly and unhealthy. Int J Obes (Lond) (2007) 1.13
Dietary fat and thrombosis. Lancet (1978) 1.12
Complement-mediated reactions to diazepam with Cremophor as solvent (Stesolid MR). Br J Anaesth (1980) 1.08
Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids. Am J Clin Nutr (1999) 1.07
Linolenate-derived polyunsaturated fatty acids and prevention of atherosclerosis. Nutr Rev (1986) 1.07
On the inhibitory effect of albumin on platelet aggregation. Thromb Res (1980) 1.06
A hypothesis on the development of acute myocardial infarction in Greenlanders. Scand J Clin Lab Invest Suppl (1982) 1.06
The apolipoprotein E polymorphism in Greenland Inuit in its global perspective. Hum Genet (1996) 1.05
Mortality from ischaemic heart disease and cerebrovascular disease in Greenland. Int J Epidemiol (1988) 1.02
Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells. Br J Pharmacol (2011) 1.01
Catalytic Enantioselective Addition of Nitro Compounds to Imines-A Simple Approach for the Synthesis of Optically Active β-Nitro-α-Amino Esters. Angew Chem Int Ed Engl (2001) 0.95
The effect of prednisone on platelet function tests. Scand J Haematol (1982) 0.94
A novel catalytic and highly enantioselective approach for the synthesis of optically active carbohydrate derivatives. J Org Chem (2000) 0.92
Intake of ruminant trans fatty acids in the Danish population aged 1-80 years. Eur J Clin Nutr (2006) 0.92
The bleeding tendency in Greenland Eskimos. Dan Med Bull (1980) 0.91
Acetylsalicylic acid, bleeding time and age. Thromb Res (1980) 0.91
The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial. Eur J Clin Invest (1992) 0.91
Lipid metabolism, atherogenesis, and haemostasis in Eskimos: the role of the prostaglandin-3 family. Haemostasis (1979) 0.90
Nocturnal polyuria in monosymptomatic nocturnal enuresis refractory to desmopressin treatment. Am J Physiol Renal Physiol (2006) 0.90
[n-3 polyunsaturated fatty acids, heart rate variability and ventricular arrhythmias in post-AMI-patients. A clinical controlled trial]. Ugeskr Laeger (1997) 0.89
Antagonist capacities of nifedipine, captopril, phenoxybenzamine, prostacyclin and indomethacin on cyclosporin A induced impairment of rat renal function. Eur J Clin Invest (1986) 0.89
Plasma lipids and lipoproteins in patients with myocardial infarction and in a control material. Acta Med Scand (1970) 0.89
Omega-3 fatty acids. Current status in cardiovascular medicine. Drugs (1994) 0.88
Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy. Diabetologia (1992) 0.88
Dietary supplementation with n-3 polyunsaturated fatty acids and human platelet function: a review with particular emphasis on implications for cardiovascular disease. J Intern Med Suppl (1989) 0.88
Catalytic Asymmetric Direct Mannich Reactions of Carbonyl Compounds with α-Imino Esters. Angew Chem Int Ed Engl (2001) 0.88
n-3 fatty acids in health and disease. Introduction. J Intern Med Suppl (1989) 0.88
Coronary heart disease in Greenland Inuit: a paradox. Implications for western diet patterns. Arctic Med Res (1989) 0.87
Platelets and atherosclerosis. A review on the role of platelets in atherosclerosis with special reference to the role of polyunsaturated 20 carbon fatty acids. Dan Med Bull (1980) 0.87
Marine oils and thrombogenesis. Prog Lipid Res (1982) 0.87
N-3 fatty acids from fish and coronary artery disease: implications for public health. Public Health Nutr (2000) 0.86
Platelet - vessel wall interaction: influence of diet. Philos Trans R Soc Lond B Biol Sci (1981) 0.86
Familial functional antithrombin III deficiency. Scand J Haematol (1980) 0.86
Familial deficiency of prostacyclin production stimulating factor in the hemolytic uremic syndrome of childhood. Thromb Res (1981) 0.86
Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol (1997) 0.86
Protein C assays in uremia. Thromb Res (1989) 0.85
Cod liver oil inhibits neutrophil and monocyte chemotaxis in healthy males. Atherosclerosis (1989) 0.84
Catalyhtic asymmetric Henry reactions--a simple approach to optically active beta-nitro alpha-hydroxy esters. Chem Commun (Camb) (2001) 0.84
Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus. Eur J Clin Nutr (2004) 0.84
Decreased interleukin-1 beta levels in plasma from rheumatoid arthritis patients after dietary supplementation with n-3 polyunsaturated fatty acids. Clin Rheumatol (1992) 0.84
Long-term supplementation with n-3 fatty acids, II: Effect on neutrophil and monocyte chemotaxis. Scand J Clin Lab Invest (1992) 0.84
The prostacyclin/thromboxane balance is favourably shifted in Greenland Eskimos. Prostaglandins (1986) 0.83
Asymmetric catalysis of 1,3-dipolar cycloaddition reactions--the concepts of activation and induction of asymmetry. Sci Prog (1999) 0.82
Hydrocortisone inhibits platelet prostaglandin and endothelial prostacyclin production. Pharmacol Res Commun (1981) 0.82
Recurrent thrombosis in a patient with factor XII deficiency. Acta Haematol (1980) 0.82
The absence of factor II in a child with systemic lupus erythematosus. Acta Paediatr Scand (1978) 0.82
Calcineurin activity in tacrolimus-treated renal transplant patients early after and 5 years after transplantation. Transplant Proc (2006) 0.81
Plasma cholesterol concentration in Caucasian Danes and Greenland West-coast Eskimos. Dan Med Bull (1977) 0.81
n-3 fatty acids and leukocyte chemotaxis. Effects in hyperlipidemia and dose-response studies in healthy men. Arterioscler Thromb (1991) 0.81
Comparison of the pharmacokinetics of tacrolimus and cyclosporine at equivalent molecular doses. Transplant Proc (2003) 0.81
Comparison of the temporal profile of calcineurin inhibition by cyclosporine and tacrolimus in renal transplant patients. Transplant Proc (2005) 0.80
Cigarette smoking and its effects on the platelet-vessel wall interaction. Scand J Clin Lab Invest (1984) 0.80
Stability of prostacyclin in plasma. Lancet (1979) 0.80
Amyl nitrite and Kaposi's sarcoma in homosexual men. N Engl J Med (1982) 0.80
Alterations in calcineurin phosphatase activity in tacrolimus-treated renal transplant patients. Transplant Proc (2002) 0.80
The effect of fish oil on lipids, coagulation and fibrinolysis in patients with angina pectoris. Artery (1988) 0.80
Platelet aggregation is not essential for xenograft rejection. Thromb Res (1986) 0.80
Cigarette smoking shortens the bleeding time. Thromb Res (1983) 0.80
Effect of trans fatty acid intake on abdominal and liver fat deposition and blood lipids: a randomized trial in overweight postmenopausal women. Nutr Diabetes (2011) 0.80
Antithrombin III and the nephrotic syndrome. Scand J Haematol (1979) 0.79
24-h monitoring of calcineurin phosphatase activity in healthy subjects. Scand J Immunol (2005) 0.79
Flush perfusion of rabbit kidneys with autogeneic, allogeneic and xenogeneic blood. Scand J Urol Nephrol (1991) 0.79
Alterations in plasma antithrombin III following total hip replacement and elective cholecystectomy. Scand J Haematol (1980) 0.79
Prostacyclin (PGI2) and the effect of phosphodiesterase inhibitors on platelet aggregation. Pharmacol Res Commun (1979) 0.79
Apolipoprotein(a) in insulin-dependent diabetic patients with and without diabetic nephropathy. Scand J Clin Lab Invest (1992) 0.79
Heart rate variability and n-3 fatty acids in patients with chronic renal failure--a pilot study. Clin Nephrol (1998) 0.79
No effect of a very low dose of n-3 fatty acids on monocyte function in healthy humans. Scand J Clin Lab Invest (1996) 0.79
omega 3 fatty acids. From eskimos to clinical cardiology--what took us so long? World Rev Nutr Diet (2001) 0.79